National Research (NASDAQ:NRC) Hits New 1-Year Low at $33.01

National Research Co. (NASDAQ:NRC)’s stock price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $33.01 and last traded at $33.01, with a volume of 1052 shares. The stock had previously closed at $33.32.

Wall Street Analysts Forecast Growth

Separately, TheStreet cut National Research from a “b-” rating to a “c+” rating in a report on Thursday, January 11th.

National Research Stock Performance

The stock has a market cap of $799.45 million, a PE ratio of 26.66 and a beta of 0.42. The stock has a fifty day simple moving average of $38.76 and a two-hundred day simple moving average of $40.25. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.67 and a current ratio of 0.67.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Tuesday, February 13th. The company reported $0.36 earnings per share for the quarter. The firm had revenue of $38.00 million during the quarter. National Research had a return on equity of 47.79% and a net margin of 20.84%.

National Research Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Friday, March 29th were given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date of this dividend was Wednesday, March 27th. National Research’s payout ratio is currently 38.40%.

Institutional Trading of National Research

Hedge funds have recently made changes to their positions in the stock. Qube Research & Technologies Ltd bought a new position in National Research during the third quarter worth $45,000. Lazard Asset Management LLC bought a new position in National Research during the first quarter worth $49,000. Gladius Capital Management LP lifted its stake in National Research by 59.8% during the fourth quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock worth $52,000 after purchasing an additional 496 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in National Research by 675.3% during the first quarter. Tower Research Capital LLC TRC now owns 1,349 shares of the company’s stock worth $59,000 after purchasing an additional 1,175 shares during the last quarter. Finally, State of Wyoming lifted its stake in National Research by 154.0% during the second quarter. State of Wyoming now owns 1,722 shares of the company’s stock worth $75,000 after purchasing an additional 1,044 shares during the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.